CLINICAL_TRIALS
trial_result
· 2015-09-09
Clinical Trial Update: Clofarabine in Chinese Pediatric Patients With Refractory or Relapsed Acute Lymphoblastic Leukemia [Phase 2]
Summary
A Phase 2 clinical trial evaluating clofarabine in Chinese pediatric patients with refractory or relapsed acute lymphoblastic leukemia has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Betta Pharmaceuticals Co., Ltd. | Conditions: Acute Lymphoblastic Leukemia | Phase 2 | Status: COMPLETED